Posts

Showing posts with the label targeted therapy

Global Breast Cancer Therapeutics Market is Anticipated to Reach US$55.8B by 2030 from US$34.8B in 2024

Image
A new report from Industry Experts Inc, on " Breast Cancer Therapeutics ," is published. According to this new global market research report, worldwide demand for Breast Cancer Therapeutics is estimated at US$34.8 billion in 2024 and is anticipated to record a CAGR of 8.2% during the 2024-2030 analysis period and stand at a projected US$55.8 billion by 2030. The breast cancer therapeutics market growth is driven by an increasing prevalence of breast cancer, greater awareness of early detection, and advancements in treatment technologies such as targeted therapies and immunotherapies. Focusing on personalized medicine, especially HER2-targeted therapies and immunotherapies, has improved patient outcomes. Moreover, the surge in innovative treatment options is being contributed by supportive government initiatives and increased investment in research and development by pharmaceutical companies. The hormone receptor segment dominates the breast cancer therapeutics...

World Cervical Cancer Treatment Market Reach about $12 billion by 2030 Driven by Advancements in Immunotherapies and Targeted Therapies

Image
A new report from Industry Experts Inc, on " Cervical Cancer Treatment ," is published. This global report reveals that the market for Cervical Cancer Treatment is estimated at US$8.6 billion in 2024 and is anticipated to post a CAGR of 5.4% during the 2024-2030 analysis period and stand at a projected US$11.8 billion by 2030. Advancements in immunotherapies and targeted therapies are driving the cervical cancer treatment market by providing more precise treatment options and reducing side effects. Immune checkpoint inhibitors, monoclonal antibodies, and personalized medicine are gaining momentum in the market, with drugs like pembrolizumab (Keytruda) demonstrating positive results in enhancing patient outcomes. Growing awareness and early screening initiatives are further driving the market demand, particularly in low- and middle-income countries where cervical cancer rates remain high. Chemotherapy dominates the cervical cancer treatment market, with an estim...